← back to search

Joseph L. Benci

Bristol-Myers Squibb (United States) · GB
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Nanoplatforms for cancer theranostics, and Immunotherapy and Immune Responses.
h-index
15
citations
6,790
works
45
NIH funding
primary concept
email

Recent publications

Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
Nature Cancer 2023cited by 101position: middledoi
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
Cell 2019cited by 547position: firstdoi
Mitotic progression following DNA damage enables pattern recognition within micronuclei
Nature 2017cited by 1,462position: middledoi
Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer
Cell 2017cited by 446position: middledoi
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Cell 2016cited by 1,145position: firstdoi
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Nature 2015cited by 2,389position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andy J. Minn · Parker Hannifin (Germany)6 papers (2015–2023)Bihui Xu · Cancer Research Institute4 papers (2015–2023)Hemant Ishwaran · University of Miami4 papers (2015–2023)E. John Wherry · Translational Therapeutics (United States)4 papers (2015–2023)Yu Qiu · Nanjing Agricultural University2 papers (2016–2017)Tara C. Gangadhar · University of Pennsylvania2 papers (2015–2016)Darwin Ye · Parker Institute for Cancer Immunotherapy2 papers (2019–2023)Christina Twyman-Saint Victor · Bristol-Myers Squibb (United States)2 papers (2015–2016)Hannah Dada · Nuffield Orthopaedic Centre2 papers (2015–2016)Ravi K. Amaravadi · University of Cincinnati Medical Center2 papers (2015–2016)Tony J. Wu · American Association For Cancer Research2 papers (2016–2017)Lynn M. Schuchter · University of Pennsylvania Health System2 papers (2015–2016)Jingya Qiu · University of Pennsylvania2 papers (2019–2023)Michael D. Feldman · Nasional University2 papers (2015–2016)Kristen E. Pauken · Brigham and Women's Hospital2 papers (2015–2016)Amit Maity · University of Utah2 papers (2015–2016)Robert H. Vonderheide · Cancer Research Institute of the Slovak Academy of Sciences2 papers (2015–2016)Yuanming Xu · UPMC Hillman Cancer Center2 papers (2019–2023)Dana Patsch · Lankenau Medical Center1 papers (2015–2015)Lisa Cucolo · Integrated BioTherapeutics (United States)1 papers (2016–2016)